KATRINA BARKER: Open Payments
NPI 1740296755 · GRAYSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 22 payments from 10 companies in 2025. Trend: 2023 $745 · 2024 $857 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
| PFIZER INC. | 4 | $74 |
| Novo Nordisk Inc | 3 | $46 |
| ABBVIE INC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Lilly USA, LLC | 2 | $30 |
| EVOKE PHARMA, INC. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CAPLYTA, NURTEC ODT, XIFAXAN, MOUNJARO, Ozempic, VRAYLAR, GIMOTI, UBRELVY.
Industry payments across KY — which companies pay providers there.
